Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass

Henry G. Bone,Michael A. Bolognese,Chui Kin Yuen,David L. Kendler,Paul D. Miller,Yu-Ching Yang,Luanda Grazette,Javier San Martin,J. Christopher Gallagher

Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass

2011

Henry G. Bone
Michael A. Bolognese
Chui Kin Yuen
David L. Kendler
Paul D. Miller
Yu-Ching Yang
Luanda Grazette
Javier San Martin
J. Christopher Gallagher

The effects of 60 mg denosumab treatment for 24 months on bone density and bone turnover are reversible upon discontinuation, reflecting its mechanism of action.

Keywords:

Bone density
Lumbar vertebrae
Bone remodeling
Bone mineral
Discontinuation
Denosumab
Endocrinology
Hip region
Internal medicine
Diabetes mellitus
Medicine
postmenopausal women

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

355

Citations